Telemedicine and Cancer Care: Barriers and Strategies to Optimize Delivery.
| Autor: | Doshi SD; From the Memorial Sloan Kettering Cancer Center, New York, NY., Bange EM, Daly B, Kuperman G, Panageas KS, Morris MJ |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cancer journal (Sudbury, Mass.) [Cancer J] 2024 Jan-Feb 01; Vol. 30 (1), pp. 8-15. |
| DOI: | 10.1097/PPO.0000000000000691 |
| Abstrakt: | Abstract: Telemedicine holds the potential to transform cancer care delivery and optimize value, access, and quality of care. A transformed regulatory environment coupled with the need to continue medical care despite operational limitations led to the rapid expansion of telemedicine in cancer care during the COVID-19 pandemic. Its utilization has since varied, and it has faced significant challenges. In this review, we will explore the state of telemedicine in cancer care delivery, the challenges it faces, and strategies to enhance its successful implementation. Competing Interests: Conflicts of Interest and Source of Funding: S.D.D. declares no conflicts of interest to disclose. E.B. reports consulting fees for Flatiron Health. B.D. reports grant support from the National Institutes of Health, participation on a data safety monitoring board or advisory board with Varian Medical Systems, and stock or stock options in Roche. G.K. and K.S.P. declare no conflicts of interest to disclose. M.J.M. reports stock and other ownership interests for Doximity; consulting or advisory role for Lantheus Medical Imaging, AstraZeneca, Amgen, Daiichi, Convergent Therapeutics, Pfizer, ITM Isotope Technologies Munich, Clarity Pharmaceuticals, Blue Earth Diagnostics, POINT Biopharma, Telix Pharmaceuticals, Progenics, and Z-Alpha; research funding from Bayer (institutional), Progenics (institutional), Corcept Therapeutics (institutional), Roche/Genentech (institutional), Janssen (institutional), Celgene (institutional), Novartis (institutional), and Astellas Pharma (institutional); and travel, accommodations, and expenses from AstraZeneca, APCCC, and Memorial Sloan Kettering Cancer Center. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|